News
14 Jul 2022
Rhodiola rosea review
Review of Rhodiola rosea
The Natac scientific team led by José Carlos Quintela have just published a review of Rhodiola rosea in the medical journal Molecules (MDPI) in June.
The literature analysis reviews 21 separate clinical studies into rhodiola’s effectiveness and discusses the plant's activity across the five key areas of: neuroprotection, anxiety and depression, physical strength and endurance, cardio protection, and reproduction. Rhodiola´s properties as an adaptogen are discussed and its major phytochemical constituents of rosavins and salidroside are brought into clinical focus.
Mentioned Companies
Natac
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance